In the APP/PS1 and 3xTg mouse models of AD, antibody-mediated depletion of neutrophils, another immune cell type that produces IL-17A, was sufficient to ameliorate memory deficits (Zenaro et al. 2015). This evidence concerns the gene IL17A and Alzheimer disease.